N@N

Market Maker Surveillance Report. WTSLA, KO, AEZS, THC, KRFT, ZLCS, Highest Net Sell Volume and Negative Price Friction For We

October 3, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4036 companies with "abnormal" market making, 2396 companies with positive Friction Factors and 2960 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Wednesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Wet Seal Inc (NASDAQ:WTSLA), The Coca-Cola Co (NYSE:KO), AETERNA ZENTARIS INC (NASDAQ:AEZS), Tenet Healthcare Corp (NYSE:THC), KRAFTWARE CORP (:KRFT), Zalicus Inc (NASDAQ:ZLCS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  WTSLA   $-0.020   -0.63%    1,270,545    25.83%    3,647,552    74.16%    -2,377,007   -1,188,504
  KO      $-0.100   -0.25%    3,190,152    24.29%    5,145,070    39.17%    -1,954,918   -195,492
  AEZS    $-0.110   -15.65%   2,220,153    37.63%    3,679,089    62.37%    -1,458,936   -132,631
  THC     $-0.060   -0.93%    2,965,156    24.23%    5,442,668    44.47%    -2,477,512   -412,919
  KRFT    $-0.220   -0.48%    10,183,720   38.59%    15,915,741   60.30%    -5,732,021   -260,546
  ZLCS    $-0.060   -7.41%    1,679,389    34.91%    3,130,878    65.09%    -1,451,489   -241,915

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows WTSLA down $-0.02000 with a Friction Factor of -1,188,504 and a Net Volume of -2,377,007. That means that it takes 1,188,504 more shares of selling than buying to drop WTSLA by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

Wet Seal Inc (NASDAQ:WTSLA) - The Wet Seal, Inc., a specialty retailer, operates stores that sell fashionable and contemporary apparel and accessory items designed for female customers. The company operates two primarily mall-based chains of retail stores under the Wet Seal and Arden B names. Its Wet Seal stores provide fashionable and basic apparel, and accessories for teenage girls; and Arden B stores offer contemporary collections of fashion, basic separates, and accessories for the feminine contemporary woman. In addition, the company operates Web-based stores, including wetseal.com that provides Wet Seal merchandise; and ardenb.com, which offers Arden B apparel and accessories. As of May 1, 2010, it had 501 stores, including 422 Wet Seal stores and 79 Arden B stores in 47 states, the District of Columbia, and Puerto Rico. The company was founded in 1962 and is based in Foothill Ranch, California..

The Coca-Cola Co (NYSE:KO) - The Coca-Cola Company manufactures, distributes, and markets nonalcoholic beverage concentrates and syrups worldwide. It principally offers sparkling and still beverages. The companys sparkling beverages include nonalcoholic ready-to-drink beverages with carbonation, such as energy drinks, and carbonated waters and flavored waters. Its still beverages consist of nonalcoholic beverages without carbonation, including noncarbonated waters, flavored waters and enhanced waters, noncarbonated energy drinks, juices and juice drinks, ready-to-drink teas and coffees, and sports drinks. The Coca-Cola Company also offers fountain syrups, syrups, and concentrates, such as flavoring ingredients and sweeteners. It markets its nonalcoholic beverages primarily under the Coca-Cola, Diet Coke, Fanta, and Sprite names. The company sells its finished beverage products primarily to distributors, and beverage concentrates and syrups to bottling and canning operators, distributors, fountain wholesalers, and fountain retailers. The Coca-Cola Company was founded in 1886 and is headquartered in Atlanta, Georgia..

AETERNA ZENTARIS INC (NASDAQ:AEZS) - terna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrinology. Its lead oncology compounds include perifosine, an orally active PI3K/Akt pathway inhibitor that is in Phase III registration trial for multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of advanced ovarian and endometrial cancer. The companys lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for Adult Growth Hormone Deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada..

Tenet Healthcare Corp (NYSE:THC) - Tenet Healthcare Corporation, an investor-owned health care services company, operates general hospitals and related health care facilities. The companys general hospitals offer acute care services, radiology services, and respiratory therapy services, as well as operate operating and recovery rooms, and clinical laboratories and pharmacies. It also provides intensive care, critical care and/or coronary care units, and physical therapy; orthopedic, oncology, and outpatient services; tertiary care services, such as open-heart surgery, neonatal intensive care, and neuroscience; quaternary care in areas, including heart, lung, liver, and kidney transplants; gamma-knife brain surgery; cyberknife surgery for tumors and lesions in the brain, lung, neck, and spine; and bone marrow transplants. As of December 31, 2008, Tenet Healthcare Corporation operated 53 general hospitals; and a critical access hospital with a combined total of 14,352 licensed beds serving urban and rural communities. The company also operated various related health care facilities, including a rehabilitation hospital; a long-term acute care hospital; a skilled nursing facility; various medical office buildings; and physician practices, captive insurance companies, and other ancillary health care businesses, such as outpatient surgery centers, diagnostic imaging centers, and occupational and rural health care clinics, as well as owned interests in two health maintenance organizations. It has a joint venture agreement with MED3000 Inc. to provide services to physician practices. The company was founded in 1967 and is headquartered in Dallas, Texas with additional offices in Santa Ana, California; Coral Springs, Florida; and Philadelphia, Pennsylvania..

KRAFTWARE CORP (:KRFT) - KRAFTWARE CORP.

Zalicus Inc (NASDAQ:ZLCS) - Zalicus Inc., a biopharmaceutical company, discovers and develops drug candidates focusing on the treatment of pain and inflammation. The company'?s clinical and preclinical product candidates include Synavive, a glucocorticoid prednisolone product candidate, which is in Phase IIb clinical trial for the treatment of rheumatoid arthritis; Z160, an N-type calcium channel blocker that has completed Phase I clinical trial to treat neuropathic and inflammatory pain; and Z944, an oral T-type calcium channel blocker, which is in Phase I clinical trial for the treatment of various chronic pain conditions, as well as sodium channels to treat acute and chronic inflammatory, and neuropathic pain. It has research collaboration agreement with Hydra Biosciences, Mallinckrodt Inc., and Amgen Inc.; research and license agreement with Fovea Pharmaceuticals SA and Novartis; and cooperative research and development agreement with the United States Army Medical Research Institute for Infectious Diseases. The company was formerly known as CombinatoRx, Incorporated and changed its name to Zalicus Inc. in September 2010. Zalicus Inc. was founded in 2000 and is based in Cambridge, Massachusetts..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net